Zim Laboratories Ltd - ZIM LABORATORIES Share Price

Sector: Pharmaceuticals | ISIN: INE518E01015
₹ 107.10 (4.74%) icon2 Jun, 2023, 3:44:02 PM

Zim Laboratories Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 6/2/2023 3:44:02 PM

    ₹ 107.1 4.85 4.74
  • Open
  • ₹ 105
  • Prev. Close
  • ₹ 102.25
  • Turnover(Lac.)
  • ₹ 138
  • Day's High
  • ₹ 107.35
  • Day's Low
  • ₹ 103.4
  • 52 Week's High
  • ₹ 124.35
  • 52 Week's Low
  • ₹ 68.05
  • Book Value
  • ₹ 40.04
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 521.85
  • P/E
  • 20.82
  • EPS
  • 5.13
  • Divi. Yield
  • 0

Zim Laboratories Ltd Corporate Actions

10 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2023

12:00 AM

23 Dec , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Dec , 2022

12:00 AM

12 Nov , 2022

12:00 AM

05 Nov , 2022

12:00 AM

05 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Aug , 2022

12:00 AM

AGM

Announcement date: 29 Aug , 2022

View Details

19 Jul , 2022

12:00 AM

19 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Jun , 2022

12:00 AM

06 Jun , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Aug , 2022

12:00 AM

BookCloser

View Details

Zim Laboratories Ltd SHAREHOLDING SNAPSHOT
03 June , 2023 | 12:38 PM

PROMOTER - TOTAL33.26%

Indian: 33.26%

Foreign: 0%

NON-PROMOTER - TOTAL 66.74%

Institutions: 0.00%

Non-Institutions: 66.74%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Zim Laboratories Ltd News and Update

Image not found
  • 1 day ago |
  • 5:44 PM

According to Aditya Birla Capital Ltd., the preferential issuance would take place at a cost of Rs 165.1 per equity share and is pending approval from shareholders.

Image not found
Image not found
  • IIFL News Service |
  • 29 May, 2023 |
  • 5:39 PM
Article Image
  • IIFL News Service |
  • 25 May, 2023 |
  • 5:32 PM
ad IconAd Image

Zim Laboratories Ltd FINANCIALS

Zim Laboratories Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Zim Laboratories Ltd

  • Anwar S Daud
  • Chairman & Managing Director
  • Zulfiquar M Kamal
  • Director (Finance)
  • Prakash Sapkal
  • Director (Operation)
  • Niraj Dhadiwal
  • Director (Business Developmnt)
  • Kavita Loya
  • Non-Exec. & Independent Dir.
  • Padmakar Joshi
  • Non-Exec. & Independent Dir.
  • Piyush Nikhadi
  • Company Sec. & Compli. Officer
  • Kamlesh Shende
  • Independent Director
  • Kakasaheb Mahadik
  • Independent Director

Summary

428407/02/96VATSALA Zim Laboratories Ltd --------------------------------------------------The Company was incorporated in the state of Maharashtra under the name and style of Zim Laboratories Pvt. Ltd. The company is engaged in manufacturing pharmaceutical products in the form of Tablets, Capsules and Syrups. The Company became a Public Ltd. Company by passing special resolution and fresh certificate of incorporation was obtained from Registrar of the Companies, Maharashtra, Bombay. The company commenced commercial production and there was no delay in implementation of the project.The company is presently engaged in the manufacturing and trading of a variety of formulations in the field of antibiotics, antibacterials, analgesics, etc. both as branded and generic products. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI... Read More


Reports by Zim Laboratories Ltd


Reports by Zim Laboratories Ltd